Compare NEU & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEU | BIO |
|---|---|---|
| Founded | 1887 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 8.2B |
| IPO Year | N/A | N/A |
| Metric | NEU | BIO |
|---|---|---|
| Price | $710.62 | $302.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $358.50 |
| AVG Volume (30 Days) | 109.0K | ★ 158.3K |
| Earning Date | 02-02-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.68% | N/A |
| EPS Growth | ★ 5.10 | N/A |
| EPS | ★ 47.34 | N/A |
| Revenue | ★ $2,744,413,000.00 | $2,557,500,000.00 |
| Revenue This Year | N/A | $1.62 |
| Revenue Next Year | N/A | $2.26 |
| P/E Ratio | $15.05 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $480.00 | $211.43 |
| 52 Week High | $875.97 | $373.69 |
| Indicator | NEU | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 35.95 | 42.26 |
| Support Level | $705.38 | $295.01 |
| Resistance Level | $731.50 | $307.07 |
| Average True Range (ATR) | 19.85 | 8.09 |
| MACD | -3.79 | -1.25 |
| Stochastic Oscillator | 9.60 | 22.23 |
NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives. Petroleum additives are used in lubricating oils and fuels to enhance their performance in machinery, vehicles, and other equipment. It comprises two broad product applications. Lubricant additives are formulated chemical solutions that, when blended with base fluids, improve the efficiency, durability, performance, and functionality of mineral oils, synthetic oils, and biodegradable fluids. Fuel additives are chemical components that help oil refiners meet fuel specifications or formulated packages that improve the performance of gasoline, diesel, biofuels, and other fuels.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.